Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD).
Mitchell SA, Leidy NK, Mooney KH, Dudley WN, Beck SL, LaStayo PC, Cowen EW, Palit P, Comis LE, Krumlauf MC, Avila DN, Atlam N, Fowler DH, Pavletic SZ. Mitchell SA, et al. Among authors: krumlauf mc. Bone Marrow Transplant. 2010 Apr;45(4):762-9. doi: 10.1038/bmt.2009.238. Epub 2009 Sep 28. Bone Marrow Transplant. 2010. PMID: 19784078 Free PMC article.
Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation.
Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW, Datiles MB, Hakim FT, Kleiner DE, Krumlauf MC, Pavletic SZ. Imanguli MM, et al. Among authors: krumlauf mc. Biol Blood Marrow Transplant. 2010 Oct;16(10):1362-9. doi: 10.1016/j.bbmt.2010.03.023. Epub 2010 Mar 28. Biol Blood Marrow Transplant. 2010. PMID: 20353829 Free PMC article.
A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.
Mitchell SA, Jacobsohn D, Thormann Powers KE, Carpenter PA, Flowers ME, Cowen EW, Schubert M, Turner ML, Lee SJ, Martin P, Bishop MR, Baird K, Bolaños-Meade J, Boyd K, Fall-Dickson JM, Gerber LH, Guadagnini JP, Imanguli M, Krumlauf MC, Lawley L, Li L, Reeve BB, Clayton JA, Vogelsang GB, Pavletic SZ. Mitchell SA, et al. Among authors: krumlauf mc. Biol Blood Marrow Transplant. 2011 Nov;17(11):1619-29. doi: 10.1016/j.bbmt.2011.04.002. Epub 2011 Apr 12. Biol Blood Marrow Transplant. 2011. PMID: 21536143 Free PMC article.
Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation.
Bishop MR, Steinberg SM, Gress RE, Hardy NM, Marchigiani D, Kasten-Sportes C, Dean R, Pavletic SZ, Gea-Banacloche J, Castro K, Hakim F, Krumlauf M, Read EJ, Carter C, Leitman SF, Fowler DH. Bishop MR, et al. Among authors: krumlauf m. Br J Haematol. 2004 Sep;126(6):837-43. doi: 10.1111/j.1365-2141.2004.05133.x. Br J Haematol. 2004. PMID: 15352988 Free article. Clinical Trial.
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapy.
Sportès C, Steinberg SM, Liewehr DJ, Gea-Banacloche J, Danforth DN, Avila DN, Bryant KE, Krumlauf MC, Fowler DH, Pavletic S, Hardy NM, Bishop MR, Gress RE. Sportès C, et al. Among authors: krumlauf mc. Biol Blood Marrow Transplant. 2009 Aug;15(8):963-70. doi: 10.1016/j.bbmt.2009.04.018. Biol Blood Marrow Transplant. 2009. PMID: 19589486 Free PMC article. Clinical Trial.
Erratum to "Salivary Gland Involvement in Chronic Graft-versus-Host Disease: Prevalence, Clinical Significance, and Recommendations for Evaluation" [Biol Blood Marrow Transplant 16:1362-1369].
Imanguli MM, Atkinson JC, Mitchell SA, Avila DN, Bishop RJ, Cowen EW, Datiles MB, Hakim FT, Kleiner DE, Krumlauf MC, Pavletic SZ. Imanguli MM, et al. Among authors: krumlauf mc. Biol Blood Marrow Transplant. 2016 Jun;22(6):1147. doi: 10.1016/j.bbmt.2015.09.026. Epub 2015 Oct 9. Biol Blood Marrow Transplant. 2016. PMID: 27179943 Free article. No abstract available.
Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation.
Hardy NM, Hakim F, Steinberg SM, Krumlauf M, Cvitkovic R, Babb R, Odom J, Fowler DH, Gress RE, Bishop MR. Hardy NM, et al. Among authors: krumlauf m. Biol Blood Marrow Transplant. 2007 Sep;13(9):1022-30. doi: 10.1016/j.bbmt.2007.05.008. Epub 2007 Jul 16. Biol Blood Marrow Transplant. 2007. PMID: 17697964 Free PMC article.
29 results